And the winner is …. cancer research

02-Dec-2013 - The three winners of the first Roche Pharma Research & Development (pRED) Oncology Awards in the field of ‘Novel Highly tumour-selective Membrane Targets for Antibody-based Cancer Therapy’ have been selected. Krishna Chaitanya of the Oncological Institute at the University Hospital Zurich ...

New Roche Award for antibody-based cancer therapy research

Researchers from academia throughout Europe are invited to participate

29-May-2013 - In a newly created award, pRED`s Discovery Oncology unit of Roche (RHHBY) in Penzberg, Germany invites European researchers to submit abstracts which describe their scientific work in the field of tumor-selective membrane targets for antibody-based cancer therapy. The award aims to honor and ...

SynenTec To Take Over Roche Cellavista System

03-Aug-2012 - Roche and SynenTec announced that Roche will transfer its Cellavista business to SynenTec, the German company which is the original inventor of the Cellavista System. This agreement was made as a result of the Roche Applied Science decision to focus its business, and guarantees future optimal ...

Sysmex and Roche renew successful alliance in the hematology business

Distributorship, sales and services agreement extends for another 10 years

17-Apr-2012 - Sysmex Corporation and Roche announced the signing of a restated 10 years distribution, sales and services agreement (“DSS Agreement”). Under the agreement, Roche will continue to distribute the Sysmex hematology products, including instruments, reagents and data management solutions in selected ...

Roche Diagnostics Announces Dan Zabrowski as New Head of Roche Applied Science

02-Feb-2012 - As of February 1, 2012, Dan Zabrowski is Head of Roche Applied Science in the Diagnostics Division, located in Penzberg, Germany. He succeeds Paul Brown who has led Roche Applied Science since September 2011. Dan Zabrowski will report to Daniel O’Day, COO Roche Diagnostics.Dan recently served as ...

Roche and Diagnostica Stago terminate partnership

07-Oct-2011 - Roche Professional Diagnostics and Diagnostica Stago announced that the companies have decided to pursue separate paths in the business of Laboratory Coagulation in the territories where Roche distributed the Stago product range. The exclusive sales of Stago products by Roche will continue ...

Roche Researchers Sequence Complete Genome of Cynomolgus Monkey

26-Sep-2011 - A team of researchers from Roche, including scientists from Roche Pharma Research and Early Development and Roche NimbleGen, reported in Genome Research that they have generated the first draft genome sequence of the cynomolgus monkey (Macaca fascicularis) and developed a novel microarray design ...

Roche Announces Thomas Schinecker as New President of 454 Life Sciences

18-Jul-2011 - 454 Life Sciences, a center of excellence of Roche’s business unit Applied Science, announced that effective August 1, 2011, Dr. Thomas Schinecker is appointed Lifecycle Leader for Sequencing and President of 454 Life Sciences, Inc., in Branford, Connecticut, USA, reporting to Robert Yates, Head ...

Roche Diagnostics Supports European Union’s DETECTIVE Project to Reduce Animal Testing

24-Jun-2011 - The xCELLigence RTCA System of Roche is being used in the European Union’s DETECTIVE ("Detection of endpoints and biomarkers for repeated dose toxicity using in vitro systems”) Project, a joint study funded by the European Cosmetics Association (Colipa) and the European Commission, where Roche is ...

Deadly E. Coli Strain Sequenced with Roche GS Junior System by HPA Scientists

Provides Community Most Complete Assembly to Date

16-Jun-2011 - The deadly E. coli O104 strain that has killed dozens and hospitalized thousands across Europe has been sequenced using 454 Life Sciences’ benchtop GS Junior sequencing system to generate the “most accurate and detailed genetic analysis to date” of this particularly virulent strain. The ...